86 reports

Gastrointestinal endoscopy examination Bronchoscopy lung examination X-ray or computed tomography (CT) scan of abdomen and chest Biopsy Diagnosis Treatment Immunotherapy Chemotherapy HAART MARKET OVERVIEW PART ##: Market landscape The global Kaposi sarcoma market is expected to benefit from

  • HIV AIDS
  • Forecast
  • Bristol-Myers Squibb Company
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • HIV AIDS
  • Asia
  • Japan
  • Gilead Sciences, Inc.
  • ViiV Healthcare Ltd.
  • ALERE: KEY TAKEAWAYS
  • MARKET SHARE ANALYSIS 2014

Alere' s POC products are available for infectious diseases such as respiratory syncytial virus (RSV), influenza, tuberculosis, pneumonia, HIV, AIDS, gastrointestinal disease, dengue, and malaria.

  • HIV AIDS
  • World
  • Alere Inc.
  • DiaSorin S.p.A.
  • Roche Group
  • Jun 13, 2016: Autologous Stem Cell Transplantation Offers Safe and Effective, and Potentially...
  • Jun 13, 2016: Autologous Stem Cell Transplantation Offers Safe and Effective, and Potentially...

gastrointestinal toxicities (roughly one week).

  • Healthcare
  • HIV AIDS
  • Therapy
  • United States
  • GlobalData's company

Eosinophils are pro-inflammatory cells that make a major contribution to allergic diseases affecting the upper and lower airways, skin and gastrointestinal tract.

  • HIV AIDS
  • United States
  • Auspex Pharmaceuticals, Inc.
  • Cephalon, Inc.
  • ChemGenex Pharmaceuticals Limited

GASTROINTESTINAL INCLUDES NEXIUM ##HR/ NEXIUM CONTROL.

  • HIV AIDS
  • Canada
  • North America
  • Mylan Inc.
  • Pfizer Inc.
  • Medestea Research & Production S.p.A. - Research and Development Overview
  • Key Therapeutic Areas

- Research and Development Overview Medestea Research & Production S. p. A. has promising clinical drug candidates for ## major therapeutic areas, Cardiovascular, Central Nervous System, Gastrointestinal, Infectious Disease, Musculoskeletal Disorders, Oncology, Respiratory, Immunology,

  • HIV AIDS
  • World
  • Product Initiative
  • Supply
  • Medestea
  • COMMON ROUTES OF VIRAL ENTRY
  • VIRAL INFECTIONS THERAPEUTICS MARKET, GLOBAL, HISTORIC AND FORECAST ANNUAL

THESE CONDITIONS MAY BE ASSOCIATED WITH SYMPTOMS SUCH AS JAUNDICE, HEMATEMESIS, DARK-COLORED URINE OR FECES, EDEMA AND GASTROINTESTINAL SYMPTOMS (NHS, 2015C).

  • Antiviral
  • HIV AIDS
  • World
  • Market Size
  • Gilead Sciences, Inc.

HIV

4546 5000 3864
  • Reyataz late-phase trial data in HIV-1 infection
  • Reyataz pivotal trial data in HIV-1 infection

Gastrointestinal (GI) toxicities were documented in a similar percentage of patients in the Tybost (##. ##%) and Norvir (##. ##%) treatment arms.

  • HIV AIDS
  • Europe
  • United States
  • World
  • Bristol-Myers Squibb Company

Cytomegalovirus - Background - Chorioretinitis - Gastrointestinal - Central Nervous System Disease - Diagnostic Tests - Vaccines and Drugs d.

  • Hepatitis
  • HIV AIDS
  • Infectious Disease
  • United States
  • World
  • HIV AIDS
  • United States
  • Company
  • Corporate Finance
  • Tobira Therapeutics, Inc.

Kymab Ltd Pharmaceuticals & Healthcare - Deals and Alliances Profile August 2017 Report Code: GDPH##D Published: Kymab Ltd (Kymab) is a biopharmaceutical company that discovers and develops fully human monoclonal antibody drugs.

  • HIV AIDS
  • Pharmaceutical
  • United Kingdom
  • United States
  • Kymab Limited
  • HIV AIDS
  • Infectious Disease
  • Vaccine
  • United States
  • GlobalData's company
  • HIV AIDS
  • Pharmaceutical
  • Therapy
  • United States
  • GlobalData's company
  • JUN 13, 2016: AUTOLOGOUS STEM CELL TRANSPLANTATION OFFERS SAFE AND EFFECTIVE, AND POTENTIALLY...
  • JUN 13, 2016: AUTOLOGOUS STEM CELL TRANSPLANTATION OFFERS SAFE AND EFFECTIVE, AND POTENTIALLY...

Its pipeline candidates are used to treat the gastrointestinal and CRC and orphan diseases.

  • Cancer
  • HIV AIDS
  • Specialty Hospital
  • United States
  • GlobalData's company
  • HIV AIDS
  • Therapy
  • Finland
  • Company
  • GlobalData's company

The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging problems, critical care or surgery, brain health, pediatrics, metabolic diseases, food allergy, obesity and chronic medical conditions.

  • HIV AIDS
  • Pharmaceutical
  • Therapy
  • United States
  • GlobalData's company
  • JUL 20, 2017: NIH-SUPPORTED SCIENTISTS ELICIT BROADLY NEUTRALIZING ANTIBODIES TO HIV IN CALVES

Its pipeline candidates are used to treat the gastrointestinal and CRC and orphan diseases.

  • HIV AIDS
  • Specialty Hospital
  • Therapy
  • United States
  • GlobalData's company

Report covers products from therapy areas Oncology, Immunology, Infectious Disease, Metabolic Disorders, Central Nervous System, Gastrointestinal, Hematological Disorders and Women' s Health which include indications Rheumatoid Arthritis, Type ## Diabetes (Juvenile Diabetes), Acute Lymph

  • HIV AIDS
  • United States
  • World
  • Product Initiative
  • Cytheris SA

The company' s pipeline products include oral combination therapy candidates for the treatment of helicobacter pylori infection, crohn' s disease and multiple sclerosis; uPA inhibitor for the treatment of gastrointestinal and other solid tumor cancers; Hsp## inhibitor for the treatm

  • HIV AIDS
  • Therapy
  • United States
  • Product Initiative
  • CytRx Corporation
  • NUMBER OF PRODUCTS UNDER DEVELOPMENT BY THERAPY AREA, H2 2016
  • PIPELINE BY GLAXOSMITHKLINE PLC, H2 2016
  • HIV AIDS
  • United States
  • World
  • Product Initiative
  • Tobira Therapeutics, Inc.

Gastrointestinal Disease Diagnosis of Gastrointestinal Diseases UNI-GOLD H.

  • HIV AIDS
  • In Vitro Diagnostics
  • United States
  • Company Financials
  • Trinity Biotech plc

Cachexia Global Clinical Trials Review, H##, 2017 HEA LTH CA REHEA LTH CA RE REFERENCE CODE: GDHC##CTIDB PUBLICATION DATE: MAY 2017 LIST OF TABLES LIST OF FIGURES Cachexia Global Clinical Trials Review, H##, 2017 outlines clinical trials in Cachexia.

  • Drug Discovery And Development
  • HIV AIDS
  • Pharmaceutical
  • World
  • Product Initiative

Gastrointestinal Tract Cancer, Melanoma, Non-Small Cell Lung Cancer, Solid Tumor Ongoing, recruiting Phase I/ II Interventional PDR-## Novartis AG ## Apr 2015 ## Apr 2015 ## Aug 2018 ## ## ## ## Programmed Cell Death Protein ## (PD## or CD## or PDCD##) Antagonist Programmed Cell Death Pr

  • HIV AIDS
  • Therapy
  • World
  • Product Initiative
  • Merck & Co., Inc.
  • LICENSING AGREEMENTS
  • LICENSING AGREEMENTS

Parion Sciences develops ENaC blockers which are used to treat lung, mouth, nose and the gastrointestinal tract.

  • Antiviral
  • Hepatitis Treatment
  • HIV AIDS
  • Pharmaceutical
  • Gilead Sciences, Inc.

The results of the combination of Lefitolimod with the checkpoint inhibitors in preclinical tumor models were presented at the Annual 2017 Gastrointestinal Cancers Symposium in San Francisco, USA (January ##-##, 2017).

  • Healthcare
  • HIV AIDS
  • Pharmaceutical
  • United States
  • MOLOGEN AG
  • PIPELINE BY OSEL INC, H2 2017
  • PIPELINE BY PHARIS BIOTEC GMBH, H2 2017

The company' s products are used in the therapeutic areas of women' s health and gastrointestinal tract disorders, including recurrent urinary tract infections, recurrent bacterial vaginosis, inflammatory bowel diseases, and antibioticassociated diarrhea.

  • HIV AIDS
  • United States
  • World
  • Product Initiative
  • Mymetics Corporation

The company offers over-the-counter products for pain relief, oral health, nutrition, skin health and gastrointestinal disorders.

  • HIV AIDS
  • Therapy
  • United States
  • Product Initiative
  • Cytheris SA
  • GLOBAL MARKETS DIRECT REPORT COVERAGE
  • FEATURED NEWS & PRESS RELEASES

NOV ##, 2016: ALLERGAN SHOWS STRONG PRESENCE AT THE AASLD LIVER MEETING WITH DATA IN POSTER SESSIONS AND AN ORAL PLENARY PRESENTATION Allergan plc, a leading global pharmaceutical company committed to the research and development of new treatments for gastrointestinal diseases, announced th

  • HIV AIDS
  • Pathology
  • Therapy
  • United States
  • Product Initiative

The company manufactures and markets pharmaceutical products for various therapeutic areas such as cardiovascular, central nervous system, oncology, dermatology, gastrointestinal, musculoskeletal system, pain management, pediatrics and the respiratory system.

  • HIV AIDS
  • Pharmaceutical
  • United Kingdom
  • Company
  • Ergomed plc